FOXD2 and nonpapillary renal cell carcinoma: FOXD2-AS1 was found to be more expressed in the hyper-risk category with a short survival time than in the hypo-risk category with a long survival time in this study, suggesting that FOXD2-AS1 may be a promoter for ccRCC, and opening up possibilities for future research.